Pros - optune
Ended Purchase Order Awarded Last action
- Contract number
- 36C25926P0315
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $49,749
Award facts
- Opportunity
-
- 36C25926AP2303 Solicitation number
- Contract value 100% obligated
- $49,748.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, NH 03801, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) awarded a firm fixed-price purchase order valued at $49,748.73 to Novocure Inc. on March 5, 2026, for the provision of OPTUNE cancer treatment systems. The purchase order, which carries no set-aside designation, is scheduled for completion by June 5, 2026, with performance at the Portsmouth, New Hampshire VA Medical Center. Novocure Inc., a medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, serves as the prime contractor with no subcontractor involvement, ensuring direct control over its proprietary cancer treatment devices.
This award is issued under Novocure's existing Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies with the VA Veterans Health Administration, a $28.85 million multiple-award vehicle established November 1, 2022, and extending through October 31, 2027. The OPTUNE system represents a non-invasive therapeutic option for solid tumor cancers, including FDA-approved applications for glioblastoma and mesothelioma. As the sole source provider of this specialized technology, Novocure has issued over 100 delivery orders and purchase orders across numerous VISNs, demonstrating the VA's strategic commitment to expanding veterans' access to innovative cancer treatment capabilities throughout the Veterans Health Administration network.
Quick answers
Who was awarded contract 36C25926P0315?
36C25926P0315 was awarded to Novocure Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on March 5, 2026.
How much is contract 36C25926P0315 worth?
The government has obligated $49,749 on 36C25926P0315.
Was contract 36C25926P0315 competed?
The extent of competition for 36C25926P0315 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award